Skip to Main Content

Paper Details

Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy.
Clin J Am Soc Nephrol
2
2023
Anti-PLA2R Antibody, Kidney Disease, Membranous Nephropathy, PLA2R, Rituximab, albumin, anti-PLA2R antibodies, anti-PLA2R antibody, anti-phospholipase A2 receptor, creatinine, cyclosporine, membranous nephropathy, patients, proteinuria, rituximab
Author NameAffiliation
Brad H RovinOhio State University Wexner Medical Center
Brad H RovinOhio State University Wexner Medical Center
Heather N ReichUniversity of Toronto
Krzysztof KirylukColumbia University
Krzysztof KirylukColumbia University
  • 1 - 5

Datasets

Release 1.2